world Pfizer wins $144.6m from AstraZeneca in US cancer drug patent trial
AstraZeneca owes Pfizer US$107.5 million (S$144.6 million) in damages, a Delaware federal jury said on Friday (May 17) after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights. The jury agreed, …